Skip to content

Predicting the Efficacy of Resistance Exercise Training for Improving Endurance Performance

Identifying Molecular Determinants for the Efficacy of Resistance Training for Improving Endurance Performance in Elite Cyclists

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04637178
Acronym
IDperform
Enrollment
25
Registered
2020-11-19
Start date
2020-11-16
Completion date
2021-02-26
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elite Cyclists

Keywords

Cycling, Endurance performance, Skeletal muscle biology, Individualization, Muscle fiber type proportions, Ribosomal RNA

Brief summary

The overall objective of the study is to identify molecular determinants of the efficacy of resistance training for improving endruance performance in elite cyclists

Detailed description

For elite endurance athletes, the addition of resistance training to habitual endurance training routines generally leads to improved endurance performance. However, this is not always the case, with several individuals failing to respond in the expected manner. This inter-individual variation is likely associated with inherent cellular and molecular charateristics of skeletal muscle. Indeed, responses to resistance training seem to be associated with muscle biological characteristics such as muscle fiber composition and ribosomal content (during the early phase of resistance training). The study will investigate the association between muscle fibre composition (type I vs type II muscle fiber proportions) / ribosomal content in m. vastus lateralis and the effects of 10 weeks of resistance training on endurance performance in 52 elite cyclists. Half the participants will perform resistance training in addition to their habitual endurance training routines, the other half will perform endurance training-only. Muscle biopsies will be sampled from m. vastus lateralis before and after the first two weeks of the intervention. For muscle fiber composition, the hypothesis is that larger proportions of type II fibers will be associated with more pronounced benefits of resistance training. For ribosomal content, the hypothesis is that higher rRNA content at baseline and larger increases in rRNA content during the initial part of the intervention will be associated with more pronounced benefits of resistance training. No changes are expected in the non-resistance training control group.

Interventions

BEHAVIORALResistance training

Resistance training sessions twice a week for ten weeks

BEHAVIORALEndurance training (habitual)

Endurance training for ten weeks (habitual routines)

Sponsors

Inland Norway University of Applied Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Participants/investigators will be blinded to muscle biological charateristics until after clean-up of main outcome variables. Participants/investigators will be aware of intervention arm affiliation.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* VO2max \> 65 ml/kg/min (male participants) * VO2max \> 50 ml/kg/min (female participants) * \>7 hours of endurance training per week for the 6 months leading up to the study

Exclusion criteria

\- having conducted regular resistance training for the last 6 months leading up to the study

Design outcomes

Primary

MeasureTime frameDescription
Performance during a 15-minute all-out cycling testChanges from before the intervention to immediately after the interventionMean power output measured during a 15-minute all-out cycling test
Performance during a 40-minute all-out cycling testChanges from before the intervention to immediately after the interventionMean power output measured during a 40-minute all-out cycling test

Secondary

MeasureTime frameDescription
Total RNA in muscle tissue (changes after two weeks)Changes from before the intervention to immediately after the initial two weeks of resistance trainingTotal RNA content in m. vastus lateralis (ug per mg tissue)
Muscle fiber proportions (before intervention)Before the interventionMuscle fiber proportions in m. vastus lateralis measured using immunohistochemistry
Muscle fiber proportions (changes after two weeks)Changes from before the intervention to immediately after the initial two weeks of resistance trainingMuscle fiber proportions in m. vastus lateralis measured using immunohistochemistry
Muscle fiber cross-sectional area (before intervention)Before the interventionCross-sectional area of muscle fibres in m. vastus lateralis measured using immunohistochemistry
Muscle fiber cross-sectional area (changes after two weeks)Changes from before the intervention to immediately after the initial two weeks of resistance trainingCross-sectional area of muscle fibres in m. vastus lateralis measured using immunohistochemistry
Myonuclear number (before intervention)Before the interventionMyonuclei per muscle fiber in m. vastus lateralis measured using immunohistochemistry
Myonuclear number (changes after two weeks)Changes from before the intervention to immediately after the initial two weeks of resistance trainingMyonuclei per muscle fiber in m. vastus lateralis measured using immunohistochemistry
rRNA expression (before intervention)Before the interventionrRNA abundances in m. vastus lateralis measured using qPCR
rRNA expression (changes after two weeks)Changes from before the intervention to immediately after the initial two weeks of resistance trainingrRNA abundances in m. vastus lateralis measured using qPCR
mRNA expression (before intervention)Before the interventionmRNA abundances in m. vastus lateralis measured using qPCR
mRNA expression (changes after two weeks)Changes from before the intervention to immediately after the initial two weeks of resistance trainingmRNA abundances in m. vastus lateralis measured using qPCR
Sprint performanceChanges from before the intervention to immediately after the interventionMean power output measured during a 10-second all-out cycling sprint
Maximal oxygen consumptionChanges from before the intervention to immediately after the interventionMaximal oxygen consumption measured during an incremental cycling exercise test to exhaustion
Maximal aerobic power outputChanges from before the intervention to immediately after the interventionMaximal aerobic power output measured as mean power output during the last minute of an incremental cycling exercise test to exhaustion
Power output at lactate thresholdChanges from before the intervention to immediately after the interventionPower output at 4 mmol blood lactate concentration measured during an incremental cycling exercise test (with 5 minute steps)
Gross efficiencyChanges from before the intervention to immediately after the interventionContribution of total energy turnover to power output in the fresh and fatigued state
Fractional utilization of VO2max (incremental test)Changes from before the intervention to immediately after the interventionFractional utilization of VO2max measured at 4 mmol blood lactate concentrations measured during an incremental cycling exercise test (with 5 minute steps)
Fractional utilization of VO2max (15-minute performance test)Changes from before the intervention to immediately after the interventionFractional utilization of VO2max measured during a 15-minute performance test
Hemoglobin massChanges from before the intervention to immediately after the interventionHemoglobin mass measured using CO rebreathing (g)
Blood volumeChanges from before the intervention to immediately after the interventionBlood volume measured using CO rebreathing
Plasma volumeChanges from before the intervention to immediately after the interventionPlasma volume measured using CO rebreathing
Red blood cell volumeChanges from before the intervention to immediately after the interventionRed blood cell volume measured using CO rebreathing
HematocritChanges from before the intervention to immediately after the interventionHematocrit measured using centrifugation
Maximal concentric force productionChanges from before the intervention to immediately after the interventionMaximal concentric force production measured using a seated leg press test
Total RNA in muscle tissue (before intervention)Before the interventionTotal RNA content in m. vastus lateralis (ug per mg tissue)

Other

MeasureTime frameDescription
Endurance training volumeThroughout study completion (daily), an average of ten weeksSelf-reported endurance training volume measured as time-spent in different exercise intensity zones
Resistance training volumeThroughout study completion (daily), an average of ten weeksSelf-reported resistance training volume measured as load x repetitions

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026